在线剂量适应性放射治疗在直肠癌放射治疗中显著减少了被辐射的体积
相关实验视频
Updated: Jan 10, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.6K
Lukas Schröder1, Erik van der Bijl2, Lisa Wiersema1
1Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
概括
在线剂量适应性放射治疗 (DART) 是一种新的技术,它根据每日几何和累积剂量来调整治疗计划. 这种先进的方法节省了健康组织,同时确保了直肠癌患者的充分目标覆盖.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 在线适应性放射疗法 (OART) 通过调整治疗边缘来最大限度地减少几何不确定性.
- 剂量适应性放射治疗 (DART) 是一个进步,适应计划的每日几何形状和以前交付的辐射剂量.
研究的目的:
- 在直肠癌患者中引入和评估在线剂量适应性放射治疗 (DART).
- 为了比较DART与传统OART在目标覆盖率和健康组织节省方面.
主要方法:
- 在1.5T MR-Linac.上接受OART治疗的14名直肠癌患者的回顾性分析.
- 用可变形图像注册用于分数5的剂量积累,将分数1-4中的剂量纳入其中.
- 使用临床规划目标体积 (PTV) 边际,将DART计划结果与传统OART进行比较.
主要成果:
- 在90%以上的患者中,DART获得了足够的CTV D99%,与OART相比,平均减少了0.5 Gy.
- 辐射体积显著减少:PTV周围1厘米环中的中位数剂量减少了3.6 Gy.
- 接受95%的处方剂量的患者体积减少了32% (221厘米3).
结论:
- 在线DART技术上可用于直肠癌治疗.
- DART确保了足够的累积CTV剂量传递.
- 与传统的OART相比,DART大大节省了健康的组织.
相关概念视频
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
198
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
198

